Clinical Trial Update: Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating intravenous atorvastatin in hypercholesterolemia; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypercholesterolemia

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Hypercholesterolemia, Dyslipidemias | Phase 2 | Status: COMPLETED | Results posted: 2022-07-15